A Safety, Tolerability and Pharmacodynamics Study of ACE-011 (ActRIIA-IgG1) in Healthy Postmenopausal Women

计划入组 40 人 · 首次发布于 2008 年 7 月 3 日

Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.

计划入组 150 人 · 首次发布于 2010 年 3 月 4 日

Glycoprotein IIb/IIIa Inhibitors Versus Standard Therapy in Patients with Myocardial Infarction and No-reflow

计划入组 120 人 · 首次发布于 2016 年 4 月 15 日

Saturno IIB Association

Urokinase plasminogen activator (Baker IDI Heart & Diabetes Institute/University of Melbourne)

GDF8 inhibitor (Rigel Pharmaceuticals)

aktiia SA

Switzerland

Antria, Inc.

United States

Atridia Pty Ltd.

Australia

AliveGen's ALG-801 Demonstrates Superior Efficacy Over Standard PAH Therapies in Preclinical Studies

AliveGen's ALG-801 Receives FDA Orphan Drug Designation for Pulmonary Arterial Hypertension

EMA Approves Moleculin's Phase IIb/III Trial Application for AML Treatment